

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.96731853 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.96731853 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.86744862 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 5.86744862 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.83542816 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.83542816 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.27918808 |
| 8 | intestinal cholesterol absorption (GO:0030299) | 5.16090699 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.10261672 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.97118347 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.88883006 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.88883006 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.81687277 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.81140424 |
| 15 | cysteine metabolic process (GO:0006534) | 4.73929228 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 4.64360333 |
| 17 | protein retention in ER lumen (GO:0006621) | 4.46129790 |
| 18 | valine metabolic process (GO:0006573) | 4.42313999 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.41269800 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.37330749 |
| 21 | kynurenine metabolic process (GO:0070189) | 4.32665908 |
| 22 | positive thymic T cell selection (GO:0045059) | 4.32659150 |
| 23 | COPII vesicle coating (GO:0048208) | 4.30524992 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.27838760 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 4.25832366 |
| 26 | exocrine pancreas development (GO:0031017) | 4.20212689 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 4.18914417 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 4.18914417 |
| 29 | tryptophan catabolic process (GO:0006569) | 4.18914417 |
| 30 | detection of bacterium (GO:0016045) | 4.17683091 |
| 31 | lysine catabolic process (GO:0006554) | 4.14024641 |
| 32 | lysine metabolic process (GO:0006553) | 4.14024641 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.10662579 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.10662579 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 4.10662579 |
| 36 | positive regulation by symbiont of host defense response (GO:0052509) | 4.10662579 |
| 37 | modulation by symbiont of host defense response (GO:0052031) | 4.10662579 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.10662579 |
| 39 | tryptophan metabolic process (GO:0006568) | 4.09653223 |
| 40 | 4-hydroxyproline metabolic process (GO:0019471) | 4.09375913 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.09342516 |
| 42 | protein carboxylation (GO:0018214) | 4.09342516 |
| 43 | leukocyte aggregation (GO:0070486) | 4.09104290 |
| 44 | thymic T cell selection (GO:0045061) | 4.07541888 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.05710529 |
| 46 | negative thymic T cell selection (GO:0045060) | 4.04812830 |
| 47 | detection of other organism (GO:0098543) | 4.01107306 |
| 48 | response to muramyl dipeptide (GO:0032495) | 3.99994802 |
| 49 | response to peptidoglycan (GO:0032494) | 3.99916931 |
| 50 | homocysteine metabolic process (GO:0050667) | 3.95463884 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.94835557 |
| 52 | bile acid biosynthetic process (GO:0006699) | 3.92508611 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92154893 |
| 54 | urea metabolic process (GO:0019627) | 3.89833077 |
| 55 | urea cycle (GO:0000050) | 3.89833077 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 3.89144181 |
| 57 | cellular modified amino acid catabolic process (GO:0042219) | 3.86280619 |
| 58 | NIK/NF-kappaB signaling (GO:0038061) | 3.85080124 |
| 59 | complement activation, alternative pathway (GO:0006957) | 3.80439577 |
| 60 | negative T cell selection (GO:0043383) | 3.80197373 |
| 61 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.80120928 |
| 62 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.79791343 |
| 63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.78815771 |
| 64 | negative regulation of fibrinolysis (GO:0051918) | 3.78374117 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 3.76197213 |
| 66 | regulation of cholesterol homeostasis (GO:2000188) | 3.72835074 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 3.72494808 |
| 68 | positive regulation of B cell differentiation (GO:0045579) | 3.71514911 |
| 69 | T cell selection (GO:0045058) | 3.70964662 |
| 70 | aromatic amino acid family metabolic process (GO:0009072) | 3.67333987 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 3.65966034 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.65845295 |
| 73 | positive regulation of nuclease activity (GO:0032075) | 3.64347621 |
| 74 | nitrogen cycle metabolic process (GO:0071941) | 3.62217780 |
| 75 | 2-oxoglutarate metabolic process (GO:0006103) | 3.57690015 |
| 76 | regulation of triglyceride catabolic process (GO:0010896) | 3.57512502 |
| 77 | regulation of protein activation cascade (GO:2000257) | 3.56843589 |
| 78 | regulation of fibrinolysis (GO:0051917) | 3.55200496 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 3.54263186 |
| 80 | bile acid metabolic process (GO:0008206) | 3.52404950 |
| 81 | alpha-amino acid catabolic process (GO:1901606) | 3.51463465 |
| 82 | reverse cholesterol transport (GO:0043691) | 3.47955080 |
| 83 | glycine metabolic process (GO:0006544) | 3.46155045 |
| 84 | intestinal absorption (GO:0050892) | 3.45029315 |
| 85 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.43968512 |
| 86 | triglyceride homeostasis (GO:0070328) | 3.43053621 |
| 87 | acylglycerol homeostasis (GO:0055090) | 3.43053621 |
| 88 | amino-acid betaine metabolic process (GO:0006577) | 3.42902062 |
| 89 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.42434347 |
| 90 | negative regulation of sterol transport (GO:0032372) | 3.42324729 |
| 91 | negative regulation of cholesterol transport (GO:0032375) | 3.42324729 |
| 92 | tolerance induction (GO:0002507) | 3.40459537 |
| 93 | cellular amino acid catabolic process (GO:0009063) | 3.37982399 |
| 94 | tyrosine metabolic process (GO:0006570) | 3.37573411 |
| 95 | phospholipid efflux (GO:0033700) | 3.37229888 |
| 96 | positive T cell selection (GO:0043368) | 3.35511364 |
| 97 | macrophage activation involved in immune response (GO:0002281) | 3.35481557 |
| 98 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.33836210 |
| 99 | coenzyme catabolic process (GO:0009109) | 3.33708920 |
| 100 | regulation of complement activation (GO:0030449) | 3.33678437 |
| 101 | signal peptide processing (GO:0006465) | 3.32747407 |
| 102 | regulation of nuclease activity (GO:0032069) | 3.32376690 |
| 103 | fatty acid beta-oxidation (GO:0006635) | 3.31910589 |
| 104 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.31447340 |
| 105 | serine family amino acid metabolic process (GO:0009069) | 3.31357887 |
| 106 | bile acid and bile salt transport (GO:0015721) | 3.31055442 |
| 107 | germinal center formation (GO:0002467) | 3.29865872 |
| 108 | tricarboxylic acid metabolic process (GO:0072350) | 3.26886197 |
| 109 | regulation of B cell differentiation (GO:0045577) | 3.26168034 |
| 110 | mannose metabolic process (GO:0006013) | 3.26146281 |
| 111 | protein-lipid complex remodeling (GO:0034368) | 3.24767530 |
| 112 | macromolecular complex remodeling (GO:0034367) | 3.24767530 |
| 113 | plasma lipoprotein particle remodeling (GO:0034369) | 3.24767530 |
| 114 | fatty acid oxidation (GO:0019395) | 3.24439937 |
| 115 | cellular ketone body metabolic process (GO:0046950) | 3.23891312 |
| 116 | branched-chain amino acid metabolic process (GO:0009081) | 3.23621323 |
| 117 | cellular response to unfolded protein (GO:0034620) | 3.22287592 |
| 118 | aspartate family amino acid catabolic process (GO:0009068) | 3.21076658 |
| 119 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.20327521 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.19298084 |
| 121 | endocrine pancreas development (GO:0031018) | 3.18748884 |
| 122 | fatty acid catabolic process (GO:0009062) | 3.18610579 |
| 123 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.16658580 |
| 124 | serine family amino acid biosynthetic process (GO:0009070) | 3.16521858 |
| 125 | negative regulation of interleukin-12 production (GO:0032695) | 3.16194267 |
| 126 | lipid oxidation (GO:0034440) | 3.15839413 |
| 127 | oxaloacetate metabolic process (GO:0006107) | 3.15252625 |
| 128 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.14083020 |
| 129 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.14083020 |
| 130 | ER-nucleus signaling pathway (GO:0006984) | 3.13779392 |
| 131 | indolalkylamine metabolic process (GO:0006586) | 3.13475809 |
| 132 | regulation of cholesterol esterification (GO:0010872) | 3.12055487 |
| 133 | branched-chain amino acid catabolic process (GO:0009083) | 3.10376049 |
| 134 | organic acid catabolic process (GO:0016054) | 3.09747941 |
| 135 | carboxylic acid catabolic process (GO:0046395) | 3.09747941 |
| 136 | ethanol oxidation (GO:0006069) | 3.09446438 |
| 137 | regulation of mast cell degranulation (GO:0043304) | 3.09399832 |
| 138 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.08678273 |
| 139 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.08678273 |
| 140 | monocarboxylic acid catabolic process (GO:0072329) | 3.07243867 |
| 141 | cellular response to topologically incorrect protein (GO:0035967) | 3.05965854 |
| 142 | Peyers patch development (GO:0048541) | 3.05578601 |
| 143 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.05578601 |
| 144 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.05206029 |
| 145 | detection of external biotic stimulus (GO:0098581) | 3.05036842 |
| 146 | plasma lipoprotein particle clearance (GO:0034381) | 3.04640473 |
| 147 | transcytosis (GO:0045056) | 3.04075508 |
| 148 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.03067250 |
| 149 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.03048230 |
| 150 | respiratory burst (GO:0045730) | 3.00580980 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99407114 |
| 152 | T cell migration (GO:0072678) | 2.98995141 |
| 153 | negative regulation of phagocytosis (GO:0050765) | 2.98090014 |
| 154 | response to host immune response (GO:0052572) | 2.96163743 |
| 155 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96163743 |
| 156 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.96149179 |
| 157 | defense response to protozoan (GO:0042832) | 2.95446778 |
| 158 | cellular response to type I interferon (GO:0071357) | 2.93910539 |
| 159 | type I interferon signaling pathway (GO:0060337) | 2.93910539 |
| 160 | response to type I interferon (GO:0034340) | 2.93504595 |
| 161 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.90554161 |
| 162 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.89843387 |
| 163 | response to host (GO:0075136) | 2.89843387 |
| 164 | response to host defenses (GO:0052200) | 2.89843387 |
| 165 | regulation of leukocyte degranulation (GO:0043300) | 2.88987099 |
| 166 | cellular extravasation (GO:0045123) | 2.86731560 |
| 167 | B cell mediated immunity (GO:0019724) | 2.85391748 |
| 168 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84234727 |
| 169 | negative regulation of innate immune response (GO:0045824) | 2.83283694 |
| 170 | response to interleukin-15 (GO:0070672) | 2.82280992 |
| 171 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81389056 |
| 172 | response to protozoan (GO:0001562) | 2.80284126 |
| 173 | mature B cell differentiation involved in immune response (GO:0002313) | 2.78575141 |
| 174 | negative regulation of T cell mediated immunity (GO:0002710) | 2.77471890 |
| 175 | detection of biotic stimulus (GO:0009595) | 2.75495190 |
| 176 | modulation by virus of host process (GO:0019054) | 2.75004683 |
| 177 | regulation of antigen processing and presentation (GO:0002577) | 2.74302193 |
| 178 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72873452 |
| 179 | B cell homeostasis (GO:0001782) | 2.70112001 |
| 180 | regulation of necroptotic process (GO:0060544) | 2.69688090 |
| 181 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.68253287 |
| 182 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.67376416 |
| 183 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67277975 |
| 184 | myeloid cell activation involved in immune response (GO:0002275) | 2.66372142 |
| 185 | negative regulation of B cell apoptotic process (GO:0002903) | 2.66314965 |
| 186 | neutrophil activation (GO:0042119) | 2.62294865 |
| 187 | lymphocyte homeostasis (GO:0002260) | 2.57535962 |
| 188 | regulation of necrotic cell death (GO:0010939) | 2.55696251 |
| 189 | regulation of T cell tolerance induction (GO:0002664) | 2.55519343 |
| 190 | myeloid dendritic cell activation (GO:0001773) | 2.54172428 |
| 191 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54002033 |
| 192 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.53839449 |
| 193 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.53781607 |
| 194 | modulation by symbiont of host cellular process (GO:0044068) | 2.53582620 |
| 195 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.53241943 |
| 196 | T cell homeostasis (GO:0043029) | 2.51292771 |
| 197 | regulation of superoxide anion generation (GO:0032928) | 2.48192170 |
| 198 | myeloid dendritic cell differentiation (GO:0043011) | 2.47544760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.01695026 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63451389 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.21359590 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.27979500 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.27328877 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.83483034 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.77353454 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.42824967 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.98111543 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.78060030 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.55499513 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.45517559 |
| 13 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.34574752 |
| 14 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.31140714 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.27863887 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26659422 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.20154596 |
| 18 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.10501241 |
| 19 | MAF_26560356_Chip-Seq_TH2_Human | 1.97289459 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97125044 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.91798978 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89616820 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87622623 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.85265300 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77666772 |
| 26 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76999604 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.69136903 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66063480 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66049859 |
| 30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.60510204 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.60150282 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59232211 |
| 33 | * MYC_22102868_ChIP-Seq_BL_Human | 1.58085208 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55441674 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.52939311 |
| 36 | * MYB_26560356_Chip-Seq_TH2_Human | 1.50423361 |
| 37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48623978 |
| 38 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47316983 |
| 39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45867181 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45386757 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45272138 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44834811 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.44735024 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42677379 |
| 45 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.40524784 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40121043 |
| 47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.39447656 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38918317 |
| 49 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.37096820 |
| 50 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35636997 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.34701163 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33332163 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33002708 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31993502 |
| 55 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.30227810 |
| 56 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28957740 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26095241 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25862244 |
| 59 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.25499975 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25361631 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24715180 |
| 62 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24488501 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24320479 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24036515 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22487784 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22413187 |
| 67 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.21358744 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17288871 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15836871 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14811877 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14811722 |
| 72 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14725527 |
| 73 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14514785 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14491637 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13273579 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13016126 |
| 77 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12272336 |
| 78 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.11597726 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11460495 |
| 80 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10322031 |
| 81 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10003809 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08849374 |
| 83 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.05299701 |
| 84 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03797160 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03410463 |
| 86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03262132 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02138150 |
| 88 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02104414 |
| 89 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01874529 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01778474 |
| 91 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.01701198 |
| 92 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01210722 |
| 93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00916308 |
| 94 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00322975 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99736726 |
| 96 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99529370 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99447273 |
| 98 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98094488 |
| 99 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97609442 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97244012 |
| 101 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97059304 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97007440 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96019140 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94818485 |
| 105 | MAF_26560356_Chip-Seq_TH1_Human | 0.94233836 |
| 106 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93641677 |
| 107 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93284736 |
| 108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92768381 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92286512 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92225060 |
| 111 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91725754 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91117507 |
| 113 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90808279 |
| 114 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90598998 |
| 115 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90438230 |
| 116 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90218063 |
| 117 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89549256 |
| 118 | P68_20966046_ChIP-Seq_HELA_Human | 0.88795707 |
| 119 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88449495 |
| 120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88002148 |
| 121 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.87861223 |
| 122 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87748413 |
| 123 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87045520 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86136506 |
| 125 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.85929249 |
| 126 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84568323 |
| 127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84556389 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84411394 |
| 129 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84379513 |
| 130 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.84261928 |
| 131 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83951869 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83823140 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.83674370 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80950593 |
| 135 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80325672 |
| 136 | MYB_26560356_Chip-Seq_TH1_Human | 0.80274322 |
| 137 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79964098 |
| 138 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79679179 |
| 139 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79359391 |
| 140 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.78957514 |
| 141 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.78957514 |
| 142 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78596888 |
| 143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.78471281 |
| 144 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.78192488 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77757542 |
| 146 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.77688107 |
| 147 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77450279 |
| 148 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76914140 |
| 149 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76891145 |
| 150 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.76436715 |
| 151 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76260501 |
| 152 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75889935 |
| 153 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.75845242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.22190537 |
| 2 | MP0005365_abnormal_bile_salt | 5.31629079 |
| 3 | MP0005360_urolithiasis | 5.00255549 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.53716015 |
| 5 | MP0005083_abnormal_biliary_tract | 3.71015826 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.57229679 |
| 7 | MP0003252_abnormal_bile_duct | 3.28710702 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.17920199 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.14560189 |
| 10 | MP0003763_abnormal_thymus_physiology | 3.14538054 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.89731344 |
| 12 | MP0003195_calcinosis | 2.83217443 |
| 13 | MP0009840_abnormal_foam_cell | 2.79893271 |
| 14 | MP0005220_abnormal_exocrine_pancreas | 2.79748105 |
| 15 | MP0009278_abnormal_bone_marrow | 2.73657720 |
| 16 | MP0001800_abnormal_humoral_immune | 2.70678583 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.61915460 |
| 18 | MP0005671_abnormal_response_to | 2.61592386 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.57876555 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.45301816 |
| 21 | MP0002419_abnormal_innate_immunity | 2.42776502 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.38469776 |
| 23 | MP0002723_abnormal_immune_serum | 2.36505349 |
| 24 | MP0001819_abnormal_immune_cell | 2.36166201 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.31216557 |
| 26 | MP0008260_abnormal_autophagy | 2.28470762 |
| 27 | MP0003868_abnormal_feces_composition | 2.25463797 |
| 28 | MP0005332_abnormal_amino_acid | 2.21930111 |
| 29 | MP0002396_abnormal_hematopoietic_system | 2.18381778 |
| 30 | MP0002398_abnormal_bone_marrow | 2.17425497 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 2.15554621 |
| 32 | MP0009785_altered_susceptibility_to | 1.99834496 |
| 33 | MP0000716_abnormal_immune_system | 1.97301381 |
| 34 | MP0000609_abnormal_liver_physiology | 1.93051121 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.90589901 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.89226245 |
| 37 | MP0002693_abnormal_pancreas_physiology | 1.88115623 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.85145894 |
| 39 | MP0002405_respiratory_system_inflammati | 1.85076517 |
| 40 | MP0001944_abnormal_pancreas_morphology | 1.81874626 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.81637514 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.80246394 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.78967495 |
| 44 | MP0002722_abnormal_immune_system | 1.77414772 |
| 45 | MP0002429_abnormal_blood_cell | 1.70634408 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.70381333 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.70352633 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.66650734 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.65701476 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.65701476 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.63487240 |
| 52 | MP0000858_altered_metastatic_potential | 1.61987400 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.60124449 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.53946094 |
| 55 | MP0002132_abnormal_respiratory_system | 1.51567393 |
| 56 | MP0004043_abnormal_pH_regulation | 1.50979673 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 1.46340446 |
| 58 | MP0006082_CNS_inflammation | 1.46298150 |
| 59 | MP0000490_abnormal_crypts_of | 1.42897346 |
| 60 | MP0001764_abnormal_homeostasis | 1.40826939 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.40004907 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.38296189 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.36825933 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.34984803 |
| 65 | MP0001853_heart_inflammation | 1.31238131 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.31128567 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 1.27798037 |
| 68 | MP0004510_myositis | 1.25072610 |
| 69 | MP0002933_joint_inflammation | 1.22259047 |
| 70 | MP0004381_abnormal_hair_follicle | 1.22055998 |
| 71 | MP0005310_abnormal_salivary_gland | 1.21024828 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 1.20218392 |
| 73 | MP0003283_abnormal_digestive_organ | 1.19979322 |
| 74 | MP0004185_abnormal_adipocyte_glucose | 1.18695587 |
| 75 | MP0000598_abnormal_liver_morphology | 1.16949590 |
| 76 | MP0002909_abnormal_adrenal_gland | 1.15639481 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13788276 |
| 78 | MP0001849_ear_inflammation | 1.13587827 |
| 79 | MP0001851_eye_inflammation | 1.12707229 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 1.12209440 |
| 81 | MP0003183_abnormal_peptide_metabolism | 1.10720512 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 1.07532695 |
| 83 | MP0004858_abnormal_nervous_system | 1.06345327 |
| 84 | MP0001756_abnormal_urination | 1.06294006 |
| 85 | MP0002998_abnormal_bone_remodeling | 1.05765087 |
| 86 | MP0002928_abnormal_bile_duct | 1.05000151 |
| 87 | MP0008469_abnormal_protein_level | 1.01883588 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.99576503 |
| 89 | MP0003186_abnormal_redox_activity | 0.99334542 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.98698891 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.98483748 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.98337407 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.96053159 |
| 94 | MP0005451_abnormal_body_composition | 0.95858509 |
| 95 | MP0005670_abnormal_white_adipose | 0.95209198 |
| 96 | MP0003959_abnormal_lean_body | 0.95151211 |
| 97 | MP0003828_pulmonary_edema | 0.94290993 |
| 98 | MP0001663_abnormal_digestive_system | 0.92061122 |
| 99 | MP0003436_decreased_susceptibility_to | 0.91563649 |
| 100 | MP0003075_altered_response_to | 0.90438461 |
| 101 | MP0000013_abnormal_adipose_tissue | 0.89695348 |
| 102 | MP0005166_decreased_susceptibility_to | 0.84869163 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.84073374 |
| 104 | MP0005408_hypopigmentation | 0.83578076 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.83142853 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.83055777 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.82726314 |
| 108 | MP0009763_increased_sensitivity_to | 0.81588093 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.79861366 |
| 110 | MP0005390_skeleton_phenotype | 0.79744243 |
| 111 | MP0004947_skin_inflammation | 0.78888052 |
| 112 | MP0001348_abnormal_lacrimal_gland | 0.77845646 |
| 113 | MP0003953_abnormal_hormone_level | 0.76930977 |
| 114 | MP0005448_abnormal_energy_balance | 0.76252520 |
| 115 | MP0006054_spinal_hemorrhage | 0.76104582 |
| 116 | MP0005334_abnormal_fat_pad | 0.75911339 |
| 117 | MP0004130_abnormal_muscle_cell | 0.75512010 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.73853246 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.72445588 |
| 120 | MP0009764_decreased_sensitivity_to | 0.71925923 |
| 121 | MP0000313_abnormal_cell_death | 0.71774520 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.70782749 |
| 123 | MP0002006_tumorigenesis | 0.70757253 |
| 124 | MP0000678_abnormal_parathyroid_gland | 0.69986441 |
| 125 | MP0002971_abnormal_brown_adipose | 0.69313762 |
| 126 | MP0002009_preneoplasia | 0.68878754 |
| 127 | MP0009931_abnormal_skin_appearance | 0.68647974 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.68495879 |
| 129 | MP0003448_altered_tumor_morphology | 0.66939441 |
| 130 | MP0002796_impaired_skin_barrier | 0.66242036 |
| 131 | MP0005621_abnormal_cell_physiology | 0.65976956 |
| 132 | MP0003091_abnormal_cell_migration | 0.65936153 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.65553601 |
| 134 | MP0001873_stomach_inflammation | 0.65032409 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.64961636 |
| 136 | MP0000604_amyloidosis | 0.64304486 |
| 137 | MP0005501_abnormal_skin_physiology | 0.62880161 |
| 138 | MP0003795_abnormal_bone_structure | 0.62463880 |
| 139 | MP0005381_digestive/alimentary_phenotyp | 0.61773886 |
| 140 | MP0003303_peritoneal_inflammation | 0.60494448 |
| 141 | MP0000681_abnormal_thyroid_gland | 0.60297545 |
| 142 | MP0008874_decreased_physiological_sensi | 0.60206379 |
| 143 | MP0003866_abnormal_defecation | 0.60066201 |
| 144 | MP0010386_abnormal_urinary_bladder | 0.59963697 |
| 145 | MP0003111_abnormal_nucleus_morphology | 0.59786434 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.59129683 |
| 147 | MP0005535_abnormal_body_temperature | 0.58838493 |
| 148 | MP0010155_abnormal_intestine_physiology | 0.58424118 |
| 149 | MP0005647_abnormal_sex_gland | 0.58175762 |
| 150 | MP0001661_extended_life_span | 0.57219752 |
| 151 | MP0003638_abnormal_response/metabolism_ | 0.56918307 |
| 152 | MP0001881_abnormal_mammary_gland | 0.56702562 |
| 153 | MP0000477_abnormal_intestine_morphology | 0.56581367 |
| 154 | MP0000613_abnormal_salivary_gland | 0.56572254 |
| 155 | MP0009780_abnormal_chondrocyte_physiolo | 0.55144956 |
| 156 | MP0000685_abnormal_immune_system | 0.54777233 |
| 157 | MP0003724_increased_susceptibility_to | 0.54760335 |
| 158 | MP0001790_abnormal_immune_system | 0.54326387 |
| 159 | MP0005387_immune_system_phenotype | 0.54326387 |
| 160 | MP0004782_abnormal_surfactant_physiolog | 0.53847818 |
| 161 | MP0002970_abnormal_white_adipose | 0.53688385 |
| 162 | MP0005025_abnormal_response_to | 0.52422734 |
| 163 | MP0009672_abnormal_birth_weight | 0.51500401 |
| 164 | MP0002896_abnormal_bone_mineralization | 0.50306388 |
| 165 | MP0003566_abnormal_cell_adhesion | 0.48602752 |
| 166 | MP0005379_endocrine/exocrine_gland_phen | 0.48418957 |
| 167 | MP0002269_muscular_atrophy | 0.48378574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.05883541 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.54827015 |
| 3 | Hypoglycemic coma (HP:0001325) | 5.51282038 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.86081485 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.64601433 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.59352216 |
| 7 | Ketosis (HP:0001946) | 4.43736883 |
| 8 | Xanthomatosis (HP:0000991) | 4.42296105 |
| 9 | Abnormality of the intrinsic pathway (HP:0010989) | 4.39392897 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.38267009 |
| 11 | Ketoacidosis (HP:0001993) | 4.30653545 |
| 12 | Hypoglycemic seizures (HP:0002173) | 4.30618802 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.30321173 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.25382367 |
| 15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.22273650 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14011044 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.94351940 |
| 18 | Cellulitis (HP:0100658) | 3.88333038 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.87758615 |
| 20 | Increased IgE level (HP:0003212) | 3.83020991 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.77482214 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.77189857 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76384062 |
| 24 | Myositis (HP:0100614) | 3.75506839 |
| 25 | Meningitis (HP:0001287) | 3.73923542 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.67783747 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.67379476 |
| 28 | Obstructive lung disease (HP:0006536) | 3.67379476 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.62144305 |
| 30 | Late onset (HP:0003584) | 3.60118558 |
| 31 | Fat malabsorption (HP:0002630) | 3.56903856 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 3.52074485 |
| 33 | Symptomatic seizures (HP:0011145) | 3.46726157 |
| 34 | Colitis (HP:0002583) | 3.45939167 |
| 35 | Recurrent viral infections (HP:0004429) | 3.44517580 |
| 36 | Complement deficiency (HP:0004431) | 3.43956398 |
| 37 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.43135032 |
| 38 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.43135032 |
| 39 | Hyperammonemia (HP:0001987) | 3.42024578 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.41417529 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 3.36595151 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34805269 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.34534928 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29097850 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.19469218 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 3.15619301 |
| 47 | Gout (HP:0001997) | 3.14425496 |
| 48 | Joint hemorrhage (HP:0005261) | 3.13276206 |
| 49 | Pustule (HP:0200039) | 3.09161489 |
| 50 | Inflammation of the large intestine (HP:0002037) | 3.08495380 |
| 51 | Hyperglycinemia (HP:0002154) | 3.07256274 |
| 52 | Hyperglycinuria (HP:0003108) | 3.01036273 |
| 53 | Hypolipoproteinemia (HP:0010981) | 2.99782011 |
| 54 | Orchitis (HP:0100796) | 2.97833771 |
| 55 | Recurrent skin infections (HP:0001581) | 2.94431979 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91693773 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91693773 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.91514223 |
| 59 | Hyperglycemia (HP:0003074) | 2.91124337 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.88441756 |
| 61 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.86812916 |
| 62 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.86778263 |
| 63 | Abnormality of glycine metabolism (HP:0010895) | 2.86778263 |
| 64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.86436599 |
| 65 | Gastrointestinal stroma tumor (HP:0100723) | 2.79833194 |
| 66 | Steatorrhea (HP:0002570) | 2.78342789 |
| 67 | Gingivitis (HP:0000230) | 2.76601880 |
| 68 | Vasculitis (HP:0002633) | 2.75954977 |
| 69 | Granulocytopenia (HP:0001913) | 2.75072485 |
| 70 | Stomatitis (HP:0010280) | 2.73003871 |
| 71 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.71152989 |
| 72 | Epidermoid cyst (HP:0200040) | 2.71106398 |
| 73 | Encephalitis (HP:0002383) | 2.67665971 |
| 74 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67592095 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 2.66505016 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66505016 |
| 77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.66293018 |
| 78 | Hypoalphalipoproteinemia (HP:0003233) | 2.64254905 |
| 79 | Abnormality of methionine metabolism (HP:0010901) | 2.61360070 |
| 80 | Urticaria (HP:0001025) | 2.60472215 |
| 81 | Abnormality of complement system (HP:0005339) | 2.60231822 |
| 82 | Hyperbilirubinemia (HP:0002904) | 2.60111477 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.58965040 |
| 84 | Verrucae (HP:0200043) | 2.56406703 |
| 85 | Papilloma (HP:0012740) | 2.56406703 |
| 86 | Mucopolysacchariduria (HP:0008155) | 2.54880730 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.54880730 |
| 88 | Pancreatitis (HP:0001733) | 2.50766097 |
| 89 | Petechiae (HP:0000967) | 2.50642181 |
| 90 | Lymphopenia (HP:0001888) | 2.48992842 |
| 91 | Osteomyelitis (HP:0002754) | 2.44327627 |
| 92 | Retrobulbar optic neuritis (HP:0100654) | 2.42796194 |
| 93 | Optic neuritis (HP:0100653) | 2.42796194 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42582447 |
| 95 | Hypertensive crisis (HP:0100735) | 2.41503643 |
| 96 | Increased IgM level (HP:0003496) | 2.39848953 |
| 97 | Chest pain (HP:0100749) | 2.39837131 |
| 98 | Myoglobinuria (HP:0002913) | 2.39499175 |
| 99 | Abnormality of T cell physiology (HP:0011840) | 2.38528117 |
| 100 | Abnormality of T cells (HP:0002843) | 2.36483658 |
| 101 | Myocardial infarction (HP:0001658) | 2.34333933 |
| 102 | Dysostosis multiplex (HP:0000943) | 2.34219950 |
| 103 | Insulin resistance (HP:0000855) | 2.31709458 |
| 104 | Metabolic acidosis (HP:0001942) | 2.31109128 |
| 105 | Vacuolated lymphocytes (HP:0001922) | 2.30709604 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29530942 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29530942 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29530942 |
| 109 | Skin nodule (HP:0200036) | 2.29361673 |
| 110 | Spontaneous hematomas (HP:0007420) | 2.29307240 |
| 111 | Sepsis (HP:0100806) | 2.29069937 |
| 112 | Increased serum ferritin (HP:0003281) | 2.28205798 |
| 113 | Epistaxis (HP:0000421) | 2.24267069 |
| 114 | Ragged-red muscle fibers (HP:0003200) | 2.24062834 |
| 115 | Increased cerebral lipofuscin (HP:0011813) | 2.23093812 |
| 116 | Polygenic inheritance (HP:0010982) | 2.20638624 |
| 117 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.19747840 |
| 118 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.17863886 |
| 119 | Menorrhagia (HP:0000132) | 2.17349735 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 2.17286805 |
| 121 | Hepatosplenomegaly (HP:0001433) | 2.17233654 |
| 122 | Abnormality of the fingertips (HP:0001211) | 2.17172366 |
| 123 | Emphysema (HP:0002097) | 2.16900517 |
| 124 | Large for gestational age (HP:0001520) | 2.16722253 |
| 125 | Thoracic kyphosis (HP:0002942) | 2.14956719 |
| 126 | IgM deficiency (HP:0002850) | 2.14266623 |
| 127 | Broad face (HP:0000283) | 2.13796437 |
| 128 | Seborrheic dermatitis (HP:0001051) | 2.13347466 |
| 129 | Hepatocellular carcinoma (HP:0001402) | 2.12821631 |
| 130 | Hypercholesterolemia (HP:0003124) | 2.09413170 |
| 131 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07107918 |
| 132 | Skin ulcer (HP:0200042) | 2.06541601 |
| 133 | Purpura (HP:0000979) | 2.05526122 |
| 134 | Pulmonary infiltrates (HP:0002113) | 2.04243991 |
| 135 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.04194327 |
| 136 | Loss of speech (HP:0002371) | 2.03775388 |
| 137 | Viral hepatitis (HP:0006562) | 2.01786775 |
| 138 | Protuberant abdomen (HP:0001538) | 2.01470776 |
| 139 | Severe combined immunodeficiency (HP:0004430) | 1.99867132 |
| 140 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99810379 |
| 141 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.99130593 |
| 142 | Hypochromic anemia (HP:0001931) | 1.98866140 |
| 143 | Autoimmune hemolytic anemia (HP:0001890) | 1.98016195 |
| 144 | Leukocytosis (HP:0001974) | 1.97743874 |
| 145 | Abdominal distention (HP:0003270) | 1.97664604 |
| 146 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.97124544 |
| 147 | Acute hepatic failure (HP:0006554) | 1.96930360 |
| 148 | Premature loss of primary teeth (HP:0006323) | 1.96692197 |
| 149 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.95997244 |
| 150 | Hypertriglyceridemia (HP:0002155) | 1.95670488 |
| 151 | Abnormality of serum amino acid levels (HP:0003112) | 1.94360354 |
| 152 | T lymphocytopenia (HP:0005403) | 1.94256596 |
| 153 | Elevated alkaline phosphatase (HP:0003155) | 1.93590061 |
| 154 | Mitral stenosis (HP:0001718) | 1.92901083 |
| 155 | Irritability (HP:0000737) | 1.92316997 |
| 156 | Easy fatigability (HP:0003388) | 1.91856721 |
| 157 | Restrictive lung disease (HP:0002091) | 1.91668065 |
| 158 | Skin rash (HP:0000988) | 1.91645791 |
| 159 | Fatigue (HP:0012378) | 1.91576740 |
| 160 | Lethargy (HP:0001254) | 1.91557276 |
| 161 | Abnormality of the thoracic spine (HP:0100711) | 1.91422384 |
| 162 | Death in childhood (HP:0003819) | 1.91003378 |
| 163 | Hemoptysis (HP:0002105) | 1.89745452 |
| 164 | Abnormal gallbladder morphology (HP:0012437) | 1.88422192 |
| 165 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88296822 |
| 166 | Obstructive sleep apnea (HP:0002870) | 1.87687085 |
| 167 | Recurrent lower respiratory tract infections (HP:0002783) | 1.86707100 |
| 168 | Limb hypertonia (HP:0002509) | 1.86392445 |
| 169 | Hemorrhage of the eye (HP:0011885) | 1.86336566 |
| 170 | Nasal polyposis (HP:0100582) | 1.85716234 |
| 171 | Delayed CNS myelination (HP:0002188) | 1.85119172 |
| 172 | Vascular calcification (HP:0004934) | 1.84634919 |
| 173 | Slow saccadic eye movements (HP:0000514) | 1.84572107 |
| 174 | Esophageal varix (HP:0002040) | 1.84522089 |
| 175 | Proximal tubulopathy (HP:0000114) | 1.83675929 |
| 176 | Abnormality of urine glucose concentration (HP:0011016) | 1.83653295 |
| 177 | Glycosuria (HP:0003076) | 1.83653295 |
| 178 | Malnutrition (HP:0004395) | 1.83204198 |
| 179 | Systemic lupus erythematosus (HP:0002725) | 1.82401828 |
| 180 | Spastic diplegia (HP:0001264) | 1.81738173 |
| 181 | Brushfield spots (HP:0001088) | 1.81660838 |
| 182 | Keratoconjunctivitis sicca (HP:0001097) | 1.81403057 |
| 183 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81321810 |
| 184 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81274022 |
| 185 | Interstitial pulmonary disease (HP:0006530) | 1.81044048 |
| 186 | Episodic fever (HP:0001954) | 1.81031392 |
| 187 | Abnormal tarsal ossification (HP:0008369) | 1.80723924 |
| 188 | Hyperuricemia (HP:0002149) | 1.80658870 |
| 189 | Increased purine levels (HP:0004368) | 1.80658870 |
| 190 | Stridor (HP:0010307) | 1.80563957 |
| 191 | Abnormality of T cell number (HP:0011839) | 1.80362217 |
| 192 | Abnormal cartilage morphology (HP:0002763) | 1.78276647 |
| 193 | Abnormality of the nasal mucosa (HP:0000433) | 1.77636195 |
| 194 | Exocrine pancreatic insufficiency (HP:0001738) | 1.77124719 |
| 195 | Reduced antithrombin III activity (HP:0001976) | 1.76972814 |
| 196 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76199707 |
| 197 | Thin bony cortex (HP:0002753) | 1.75280531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.79985179 |
| 2 | BCKDK | 5.02263768 |
| 3 | INSRR | 3.69155211 |
| 4 | TAOK3 | 3.56811214 |
| 5 | TRIB3 | 3.48424156 |
| 6 | PRPF4B | 3.39645869 |
| 7 | PKN2 | 2.97714497 |
| 8 | SMG1 | 2.83101899 |
| 9 | FLT3 | 2.69451258 |
| 10 | SIK1 | 2.67889935 |
| 11 | RIPK4 | 2.67123071 |
| 12 | FGFR4 | 2.57165347 |
| 13 | PASK | 2.51485808 |
| 14 | MAPK15 | 2.04915440 |
| 15 | PTK6 | 1.87836131 |
| 16 | TNK2 | 1.82807084 |
| 17 | MAP3K13 | 1.80707592 |
| 18 | EEF2K | 1.75701214 |
| 19 | FRK | 1.75448789 |
| 20 | IRAK3 | 1.74779035 |
| 21 | FES | 1.65381275 |
| 22 | MAP4K1 | 1.58228422 |
| 23 | MAP2K2 | 1.56698729 |
| 24 | MAP3K14 | 1.56045928 |
| 25 | ZAP70 | 1.52454606 |
| 26 | SIK3 | 1.51071669 |
| 27 | TYK2 | 1.50369622 |
| 28 | MAP3K10 | 1.49818288 |
| 29 | CDK12 | 1.47819505 |
| 30 | PIK3CG | 1.34591678 |
| 31 | HIPK2 | 1.33273487 |
| 32 | TAOK2 | 1.24959317 |
| 33 | EIF2AK3 | 1.24125285 |
| 34 | ICK | 1.23729067 |
| 35 | SIK2 | 1.21244890 |
| 36 | TBK1 | 1.20141865 |
| 37 | MAP2K3 | 1.19763602 |
| 38 | TAOK1 | 1.16413605 |
| 39 | KDR | 1.16180918 |
| 40 | EPHB1 | 1.16180216 |
| 41 | JAK3 | 1.15883328 |
| 42 | MAP3K2 | 1.10224730 |
| 43 | MAP3K3 | 1.09709525 |
| 44 | JAK1 | 1.09567370 |
| 45 | HCK | 1.07476200 |
| 46 | SCYL2 | 1.04808515 |
| 47 | MAPK11 | 1.03225842 |
| 48 | LRRK2 | 1.02226259 |
| 49 | CDK4 | 1.00401646 |
| 50 | EPHA3 | 0.99785231 |
| 51 | MARK2 | 0.99680900 |
| 52 | IKBKB | 0.99253628 |
| 53 | MAPKAPK3 | 0.99238093 |
| 54 | JAK2 | 0.97988527 |
| 55 | TXK | 0.96749752 |
| 56 | TTN | 0.96749636 |
| 57 | RIPK1 | 0.95920600 |
| 58 | BTK | 0.95493139 |
| 59 | NME2 | 0.93957875 |
| 60 | WNK4 | 0.92960652 |
| 61 | MAP3K1 | 0.88960939 |
| 62 | LYN | 0.88309727 |
| 63 | PTK2 | 0.87075059 |
| 64 | DYRK1B | 0.83171131 |
| 65 | MAP3K6 | 0.83009945 |
| 66 | BLK | 0.82586369 |
| 67 | IRAK2 | 0.80417874 |
| 68 | IRAK4 | 0.80060447 |
| 69 | PDGFRA | 0.76763081 |
| 70 | MAPK12 | 0.76186572 |
| 71 | ITK | 0.75113940 |
| 72 | LATS1 | 0.71880747 |
| 73 | TGFBR2 | 0.71748491 |
| 74 | MARK3 | 0.71689940 |
| 75 | IRAK1 | 0.70855189 |
| 76 | MST1R | 0.68484941 |
| 77 | PDK1 | 0.66082833 |
| 78 | RPS6KA4 | 0.66069907 |
| 79 | EPHA2 | 0.65844853 |
| 80 | CSK | 0.64951289 |
| 81 | IKBKE | 0.64690115 |
| 82 | GRK6 | 0.63902068 |
| 83 | MTOR | 0.62731937 |
| 84 | CAMKK1 | 0.61867238 |
| 85 | MATK | 0.60611324 |
| 86 | ARAF | 0.59321154 |
| 87 | RET | 0.59220673 |
| 88 | FGR | 0.57199108 |
| 89 | MAPK7 | 0.55202372 |
| 90 | PRKCH | 0.54892563 |
| 91 | NLK | 0.54015458 |
| 92 | MAP3K11 | 0.52553731 |
| 93 | MAP3K7 | 0.52115054 |
| 94 | MET | 0.51298936 |
| 95 | KSR2 | 0.51258532 |
| 96 | BMX | 0.50304286 |
| 97 | RPS6KB2 | 0.48438619 |
| 98 | PIM1 | 0.47941312 |
| 99 | PIM2 | 0.47487503 |
| 100 | RPS6KA2 | 0.47179035 |
| 101 | PRKAA2 | 0.46556391 |
| 102 | TESK1 | 0.46069625 |
| 103 | PAK2 | 0.45803513 |
| 104 | MAPKAPK2 | 0.44414214 |
| 105 | GSK3A | 0.41581115 |
| 106 | MYLK | 0.40992105 |
| 107 | CDK7 | 0.40806795 |
| 108 | PRKAA1 | 0.39286020 |
| 109 | MAP2K1 | 0.39126951 |
| 110 | TESK2 | 0.38697136 |
| 111 | FGFR3 | 0.37265775 |
| 112 | KIT | 0.36699314 |
| 113 | MAPK4 | 0.36686570 |
| 114 | PRKD1 | 0.36497996 |
| 115 | NEK9 | 0.36104730 |
| 116 | TEC | 0.35669030 |
| 117 | PDPK1 | 0.35640891 |
| 118 | CDK9 | 0.34447331 |
| 119 | ERBB4 | 0.34111080 |
| 120 | PRKCI | 0.33708100 |
| 121 | MAP3K8 | 0.33572266 |
| 122 | RPS6KA1 | 0.32992844 |
| 123 | FYN | 0.32205704 |
| 124 | CDC42BPA | 0.31856970 |
| 125 | SYK | 0.31764879 |
| 126 | CSF1R | 0.31133119 |
| 127 | RPS6KA6 | 0.29591693 |
| 128 | MAP2K6 | 0.29539449 |
| 129 | RPS6KL1 | 0.29025532 |
| 130 | RPS6KC1 | 0.29025532 |
| 131 | PRKD2 | 0.28999544 |
| 132 | STK10 | 0.28771140 |
| 133 | BRSK2 | 0.26528736 |
| 134 | CHUK | 0.25836500 |
| 135 | CAMK1D | 0.25408989 |
| 136 | PRKACG | 0.23954972 |
| 137 | FER | 0.23454884 |
| 138 | ILK | 0.23247032 |
| 139 | LCK | 0.22480748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.06942031 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.36379490 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.01176058 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.77643057 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64180601 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.64113247 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61713458 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.58132931 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54576911 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.49257310 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37370510 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.36734361 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28999207 |
| 14 | Protein export_Homo sapiens_hsa03060 | 2.28727201 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.26385354 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.24967947 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22199293 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20373737 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.20294216 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.19765278 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14109808 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.99509532 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.95690708 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.90822655 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.88950977 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88069743 |
| 27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.86329509 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.85028937 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84768037 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80074975 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77568495 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77294633 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73512165 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71065323 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.70198194 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.68635035 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66625001 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66191654 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.65300390 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64611925 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63909953 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63875515 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63496375 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62550843 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.61112863 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58763671 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.58470663 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.57929559 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53243129 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.51175172 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.51028899 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 1.50585152 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.50294326 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49895891 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49270233 |
| 56 | Asthma_Homo sapiens_hsa05310 | 1.48930346 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48062319 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46813684 |
| 59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44357563 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.41240146 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.41199109 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39669939 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.39109166 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38797535 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35189357 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.34340210 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33152575 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30709072 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29415992 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28787677 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28220388 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 1.25421409 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24559639 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23074175 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22091588 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18301704 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15524188 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.15200649 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15119013 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 1.14807383 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.14398671 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13193814 |
| 83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10009062 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 1.09798680 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09190380 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 1.07594480 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 1.07257231 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 1.07097829 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04110488 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03898936 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02707300 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.02459472 |
| 93 | Base excision repair_Homo sapiens_hsa03410 | 1.01923948 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.01022953 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 1.00095929 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99652413 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99535683 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98961307 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.98440305 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97443743 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96999939 |
| 102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93928496 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93569864 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92952824 |
| 105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88956993 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88518516 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.87145291 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80153660 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.79878047 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79075476 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79070521 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78144127 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.78091694 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77620591 |
| 115 | DNA replication_Homo sapiens_hsa03030 | 0.77603251 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77167697 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.76653889 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76224230 |
| 119 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73525734 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72768751 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72604346 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71060494 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69910890 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68978165 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67196407 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67138404 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66610797 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.65853543 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65750612 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.64102896 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62236436 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61689054 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61396691 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60622667 |
| 135 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60222574 |
| 136 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60209058 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59540836 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59036170 |
| 139 | Ribosome_Homo sapiens_hsa03010 | 0.58995558 |
| 140 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57334248 |
| 141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57111694 |
| 142 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56554556 |
| 143 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54926268 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54658653 |
| 145 | Lysosome_Homo sapiens_hsa04142 | 0.54222284 |
| 146 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54140557 |
| 147 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53858471 |
| 148 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53403663 |
| 149 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51695933 |
| 150 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50665583 |
| 151 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50139237 |
| 152 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49791051 |
| 153 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46084104 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45429307 |
| 155 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45400547 |
| 156 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45201598 |
| 157 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44338252 |
| 158 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42866112 |
| 159 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42543751 |
| 160 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40851289 |
| 161 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40772785 |
| 162 | Glioma_Homo sapiens_hsa05214 | 0.39824306 |
| 163 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37719561 |
| 164 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33564539 |
| 165 | Prion diseases_Homo sapiens_hsa05020 | 0.33127290 |
| 166 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32283802 |
| 167 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29611426 |
| 168 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.28618621 |
| 169 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.22485683 |
| 170 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19771538 |
| 171 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16766952 |
| 172 | Legionellosis_Homo sapiens_hsa05134 | 0.14898484 |
| 173 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14786071 |
| 174 | Bladder cancer_Homo sapiens_hsa05219 | 0.13498057 |
| 175 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.13422615 |
| 176 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.12554493 |
| 177 | Insulin secretion_Homo sapiens_hsa04911 | 0.11035323 |
| 178 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.09014579 |
| 179 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08487115 |
| 180 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.07466148 |

